← Back to Search

Cell Therapy

Fat Cell Injection for Knee Osteoarthritis (SVF Trial)

Phase < 1
Waitlist Available
Led By Claude T Moorman, MD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up year 1
Awards & highlights

SVF Trial Summary

This trial is testing a single injection of a person's own fat cells to treat knee osteoarthritis after an injury.

Who is the study for?
This trial is for adults aged 18-45 who've had significant knee trauma or surgery between 1 and 20 years ago, leading to Post-Trauma Osteoarthritis (PTOA). They should have ongoing knee pain despite trying at least two treatments like medication or physical therapy. Participants need a BMI under 35, speak English, and be able to attend follow-up visits. Pregnant women, tobacco users, those with recent knee injections or certain medical conditions are excluded.Check my eligibility
What is being tested?
The trial is testing the safety and feasibility of a single injection of autologous Adipose Derived Stromal Vascular Fraction (SVF) in treating knee PTOA. It's a before-after study conducted at two sites where participants' own processed fat tissue is used to potentially repair their injured knees.See study design
What are the potential side effects?
While specific side effects aren't listed for SVF treatment in this summary, similar procedures may cause pain at the injection site, swelling, infection risk increase and possible allergic reactions to local anesthetics used during the procedure.

SVF Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~year 1
This trial's timeline: 3 weeks for screening, Varies for treatment, and year 1 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Adverse Events
Other outcome measures
General Health scores - Patient-Reported Outcomes Measurement Information System (PROMIS 29)
Knee Pain scores - The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
Knee Pain scores - Visual Analog Scale (VAS)
+1 more

SVF Trial Design

1Treatment groups
Experimental Treatment
Group I: a single injection of autologous Adipose Derived (AD) Stromal Vascular Fraction (SVF)Experimental Treatment1 Intervention
a single injection of autologous Adipose Derived (AD) Stromal Vascular Fraction (SVF) for the treatment of knee Post Traumatic Osteoarthritis (PTOA)

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,239 Previous Clinical Trials
1,004,173 Total Patients Enrolled
7 Trials studying Osteoarthritis
674 Patients Enrolled for Osteoarthritis
Claude T Moorman, MDPrincipal InvestigatorWake Forest University Health Sciences

Media Library

Adipose Derived (AD) Stromal Vascular Fraction (SVF) (Cell Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT05515523 — Phase < 1
Osteoarthritis Research Study Groups: a single injection of autologous Adipose Derived (AD) Stromal Vascular Fraction (SVF)
Osteoarthritis Clinical Trial 2023: Adipose Derived (AD) Stromal Vascular Fraction (SVF) Highlights & Side Effects. Trial Name: NCT05515523 — Phase < 1
Adipose Derived (AD) Stromal Vascular Fraction (SVF) (Cell Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05515523 — Phase < 1
Osteoarthritis Patient Testimony for trial: Trial Name: NCT05515523 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are minors allowed to participate in this experiment?

"Patients aged 18 to 45 are eligible for this clinical trial, whereas there are 30 other trials open for minors and 583 for seniors."

Answered by AI

Are there still vacancies for individuals in this clinical trial?

"According to the clinicaltrials.gov, this particular trial has not been actively recruiting patients since October 31st 2022 and is currently inactive. Despite this, 613 other studies are presently enrolling individuals for their respective research initiatives."

Answered by AI

Who would be eligible to join this research endeavor?

"In order to be considered for the trials, potential participants must possess arthrosis and fall between 18-45 years old. A total of 10 patients will eventually join this research project."

Answered by AI

Who else is applying?

What state do they live in?
Texas
New York
Louisiana
Other
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?
1
0
2
3+
What site did they apply to?
Wake Forest University Health Sciences

Why did patients apply to this trial?

do not want knee replacement if possible. Pain in knees from a motorcycle accident when I was in my 20’s.
PatientReceived 1 prior treatment
I have tried to get adequate pain relief with several otc and rx for osteo arthritis but I haven't had any good results due to my being on Eliquis for DVT.
PatientReceived no prior treatments
I have had more than a year of Physical Therapy, Alternate Steroid and Synvisc Injections Meloxicam and all OTC meds. My Pain at on movement is 10, For Bilateral Knee Triple Compartmental Osteoarthritis, I know have worsening Spinal Arthritis as well. I entered another trial for that. I was checking for Spinal Arthritis trials and found this one. As its not covered by Insurance I cant afford to have my NP organize it with a Dr in her Practice who offers it.
PatientReceived 1 prior treatment

What questions have other patients asked about this trial?

How long does screening take? How long does the trial go for.?
PatientReceived 1 prior treatment

How responsive is this trial?

Typically responds via
Email
~7 spots leftby Feb 2025